# A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants

> **NCT01732237** · PHASE1 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-42396302
- **DRUG:** JNJ-42692507
- **DRUG:** JNJ-53773187

## Key facts

- **NCT ID:** NCT01732237
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732237, "A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01732237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*